Literature DB >> 1460487

Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores.

N Mackworth1, P Fobair, M D Prados.   

Abstract

To test a method of assessing quality of life, 200 primary brain tumor patients in an outpatient clinic answered a 20-minute questionnaire covering ten aspects of quality of life. These results were compared with Karnofsky performance scale (KPS) scores, taking age into account. Among patients with KPS 90-100 (two-thirds of the patients), the KPS alone was difficult to interpret. The questionnaire, with its specific questions related to the key dimension of well-being, provided a more definitive assessment of status. The central importance of well-being was supported by its strong statistical relationships with other dimensions. Particularly, well-being was related to freedom from depression (p < 0.0001), active social life (p < 0.0001), energy (p < 0.01), and fewer symptoms (p < 0.05). The KPS was more useful in differentiating the other one-third of the patients (KPS 50-80) but was highly sensitive to age. KPS scores, therefore, may have been unreliable. Depression, reported by half of the patients, was not predicted by the KPS when age was excluded from the regression analysis but was related to the scores in well-being and socializing. Neither depression, well-being, nor socializing was influenced by age. Thus, the questionnaire directly assessed these central, emotionally based variables, particularly among patients with satisfactory KPS. Such an assessment is especially crucial as a supplement to the KPS in evaluating brain tumor survivors, whose emotional well-being is often severely challenged by treatment after surgical excision.

Entities:  

Mesh:

Year:  1992        PMID: 1460487     DOI: 10.1007/bf00172600

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  34 in total

Review 1.  Measuring quality of life today: methodological aspects.

Authors:  D F Cella; D S Tulsky
Journal:  Oncology (Williston Park)       Date:  1990-05       Impact factor: 2.990

2.  Caring or curing: conflicts of choice.

Authors:  W Duncan
Journal:  J R Soc Med       Date:  1985-07       Impact factor: 5.344

3.  Disease as a reflection of the psyche.

Authors:  M Angell
Journal:  N Engl J Med       Date:  1985-06-13       Impact factor: 91.245

4.  Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study.

Authors:  K B Wells; R D Hays; M A Burnam; W Rogers; S Greenfield; J E Ware
Journal:  JAMA       Date:  1989-12-15       Impact factor: 56.272

5.  A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures.

Authors:  F I Fawzy; M E Kemeny; N W Fawzy; R Elashoff; D Morton; N Cousins; J L Fahey
Journal:  Arch Gen Psychiatry       Date:  1990-08

6.  Evaluation of patients with advanced cancer using the Karnofsky performance status.

Authors:  J W Yates; B Chalmer; F P McKegney
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

7.  Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters.

Authors:  S M Levy; R B Herberman; A M Maluish; B Schlien; M Lippman
Journal:  Health Psychol       Date:  1985       Impact factor: 4.267

8.  Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer.

Authors:  S Levy; R Herberman; M Lippman; T d'Angelo
Journal:  J Clin Oncol       Date:  1987-03       Impact factor: 44.544

9.  Psychiatric problems in breast cancer.

Authors:  P M Silberfarb
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

10.  Psychosocial problems among survivors of Hodgkin's disease.

Authors:  P Fobair; R T Hoppe; J Bloom; R Cox; A Varghese; D Spiegel
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

View more
  47 in total

1.  Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumour.

Authors:  A R Giovagnoli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 2.  Measuring the effect of cancer on health-related quality of life.

Authors:  D Osoba
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

Review 3.  Review on quality of life issues in patients with primary brain tumors.

Authors:  Martin J B Taphoorn; Eefje M Sizoo; Andrew Bottomley
Journal:  Oncologist       Date:  2010-05-27

4.  Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

5.  Cognitive effects of tumour and surgical treatment in glioma patients.

Authors:  Andrea Talacchi; Barbara Santini; Silvia Savazzi; Massimo Gerosa
Journal:  J Neurooncol       Date:  2010-09-28       Impact factor: 4.130

6.  The use of a simple Likert scale to measure quality of life in brain tumor patients.

Authors:  M P Rogers; J Orav; P M Black
Journal:  J Neurooncol       Date:  2001-11       Impact factor: 4.130

7.  The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

8.  Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.

Authors:  Meihua Wang; Gregory Cairncross; Edward Shaw; Robert Jenkins; Bernd Scheithauer; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperriere; Minesh Mehta; Walter Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-23       Impact factor: 7.038

9.  A new tool for grade II glioma studies: plotting cumulative time with quality of life versus time to malignant transformation.

Authors:  Emmanuel Mandonnet; Hugues Duffau; Luc Bauchet
Journal:  J Neurooncol       Date:  2011-07-09       Impact factor: 4.130

10.  Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues.

Authors:  Guy Pelletier; Marja J Verhoef; Nasreen Khatri; Neil Hagen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.